Patent details
EP4048230 Title: ORAL GLIPTIN COMPOSITIONS AND METHOD FOR PREPARATION THEREOF
Basic Information
- Publication number:
- EP4048230
- PCT Application Number:
- EP2020079945
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP207901877
- PCT Publication Number:
- WO2021078964
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ORAL GLIPTIN COMPOSITIONS AND METHOD FOR PREPARATION THEREOF
- French Title of Invention:
- COMPOSITIONS ORALES DE GLIPTINE ET LEUR PROCÉDÉ DE PRÉPARATION
- German Title of Invention:
- ORALE GLIPTINZUSAMMENSETZUNGEN UND VERFAHREN ZUR HERSTELLUNG DAVON
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 10/10/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 18/10/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 04/10/2023
- Unitary Effect Registration Date:
- 18/10/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 23/10/2020
- Grant date:
- 04/10/2023
- EP Publication Date:
- 31/08/2022
- PCT Publication Date:
- 29/04/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/10/2023
- EP B1 Publication Date:
- 04/10/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 23/10/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/07/2024
- Name:
- PHARMA-DATA S.A.
- Address:
- 19 Fokionos Negri Street, 19500 Lavrion, Greece (GR)
History of Owners
- From:
- 27/09/2023
- To:
- 05/07/2024
- Name:
- Authenda Pharmaceuticals AG
- Address:
- Neuhofstrasse 16, 8834 Schindellegi, Switzerland (CH)
Inventor
1
- Name:
- PSARRAKIS, Ioannis
- Address:
- Greece (GR)
2
- Name:
- LIOUMIS, Konstantinos
- Address:
- Greece (GR)
Priority
- Priority Number:
- 19205219
- Priority Date:
- 24/10/2019
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 9/08; A61K 47/10; A61K 47/26; A61K 47/36; A61K 47/38; A61K 31/4985; A61K 9/00; A61K 47/02; A61K 47/12; A61K 47/14; A61K 47/20; A61P 3/10;
Publication
European Patent Bulletin
1
- Issue number:
- 202340
- Publication date:
- 04/10/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202432
- Publication date:
- 07/08/2024
- Description:
- Transfer of Rights
3
- Issue number:
- 202346
- Publication date:
- 15/11/2023
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202347
- Publication date:
- 22/11/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|